Search Results 1-10 of 10639 for dapagliflozine
Dapagliflozin is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) ...
Dapagliflozin and metformin combination is also used to lower the risk of worsening of kidney disease, end stage kidney disease, cardiovascular death, and ...
Description. Dapagliflozin, saxagliptin, and metformin combination is used with proper diet and exercise to lower high blood sugar levels caused by type 2 ...
Dapagliflozin works in the kidneys to prevent absorption of glucose (blood sugar). ... Each tablet contains 5 milligrams (mg) saxagliptin and 5 mg dapagliflozin ...
The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure, disease specific biomarkers, symptoms, ...
The purpose of this study is to determine whether treatment with Dapagliflozin (DAPA) for 6 months will improve pulmonary capillary wedge pressure (PCWP) during ...
The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure disease-specific biomarkers, symptoms, ...
A Study To Evaluate The Effect Of Dapagliflozin On Renal Outcomes And Cardiovascular Mortality In Patients With Chronic Kidney Disease · More about research at ...
The purpose of this international study is to evaluate the effect of dapagliflozin 10 mg versus placebo in HFpEF patients, given once daily in addition to ...
About this study. The purpose of this study is to determine whether treatment with DAPA for 6 months will improve pulmonary capillary wedge pressure (PCWP) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.